This treatment is commonly used to address deficiencies caused by poor diet, malabsorption issues, or certain medical conditions such as pernicious anemia
Compounded products do not undergo the same FDA premarket review for safety, effectiveness, manufacturing quality, and labeling as approved finished drugs
NAD supports mitochondrial function, which theoretically complements the metabolic improvements semaglutide initiates, but this represents mechanistic logic rather than proven synergy
By one year, results may be substantial
However, this same action can lead to gastrointestinal side effects, with abdominal distension (bloating) being a commonly reported complaint
Questions are expected and answered